HPV-Related Head & Neck Cancer

Head & Neck cancers have traditionally been associated with tobacco and alcohol use. However, over the past two decades, a significant proportion of these cancers has been linked to infection with the human papillomavirus (HPV). HPV-related head and neck cancer is now recognised as a distinct clinical entity, particularly affecting the oropharynx, which includes the tonsils and tongue base.

HPV-associated cancers often affect younger, healthy individuals, unlike those caused by tobacco. Early symptoms can be very subtle; therefore, the condition may not be noticed until a persistent throat problem or a painless lump in the neck appears. Increased awareness and prompt specialist evaluation are important. HPV-related cancers generally respond effectively to treatment, making accurate and timely diagnosis the cornerstone of successful patient recovery.

HPV-related head and neck cancer involves malignant growths in the throat region caused by long-term infection with high-risk human papillomavirus, usually HPV-16. The virus spreads through intimate skin contact. While the immune system usually eradicates the virus, persistent infection can lead to viral DNA integrating into the cells lining the throat. Over several years, this process triggers abnormal changes that may eventually result in cancer.

These cancers most commonly arise in:

• Tonsils

• Base of the tongue

• Soft palate

• Back wall of the throat

Notably, HPV-driven cancers are distinct from those caused by traditional risk factors like tobacco. They are characterised by a unique biological profile that often leads to better treatment outcomes and improved survival rates.

HPV-related head and neck cancer stems from the long-term persistence of high-risk HPV. Viral proteins disrupt the body’s tumour-suppressing systems, triggering unregulated cellular growth. Medical evaluation for this malignancy is required when persistent symptoms are identified during a clinical review.

Symptoms requiring investigation include:

• A persistent, painless neck swelling

• Sore throat for more than three weeks

• Difficulty or pain when swallowing

• Any change in voice

• Ear pain without an ear infection

• Weight loss of unknown cause

• Long-standing throat discomfort

Notably, many patients do not have a background of tobacco or heavy alcohol use. The absence of these conventional risk factors can sometimes delay the suspicion and diagnosis of the condition.

Routine screening for HPV-related head and neck cancer does not exist for the general public. Medical investigation proceeds only after a review of the patient's symptoms, a physical examination, and an assessment of their response to preliminary medical treatments.

Detailed evaluations are generally recommended for:

• Patients whose throat symptoms continue despite standard care

• Individuals with a persistent lump or swelling in the neck

• Patients with imaging results indicating suspicious throat lesions

• Those with enlarged lymph nodes and no obvious infection

• Situations where diagnostic clarity is needed for future planning

Early assessment ensures that the diagnosis is accurate and that any necessary medical management is delivered without delay.

Doctors may avoid or delay extensive testing in patients who:

• Have symptoms present for only a short duration

• Show clear signs of a benign viral or bacterial infection

• Respond well to initial medical treatment

• Are medically unstable at the time of evaluation

In these cases, doctors monitor the condition or use conservative treatments for a short time before deciding whether further diagnostic investigations are necessary.

Evaluation is typically carried out by an ENT specialist or head and neck surgeon in a controlled clinical setting. Before proceeding with tests, the doctor explains why further evaluation is needed and what information the investigations may provide. Medical history, risk factors, and previous reports are reviewed.

Patients may be advised to:

• Inform the doctor about existing medical conditions

• Share details of medications being taken

• Report any recent infections or ongoing symptoms

Local examination of the mouth and throat is performed. A flexible nasoendoscope may be used to visualise deeper areas of the throat. If a suspicious area is identified, the following may be advised:

• Imaging tests such as CT scan, MRI, or PET-CT

• Fine-needle aspiration (FNA) of an enlarged lymph node

• Biopsy of the suspected lesion

The biopsy sample is analysed in the laboratory to confirm cancer and determine whether it is HPV-related. Special tests, such as p16 staining, are often used to identify HPV-associated tumours.

The evaluation process aims to determine:

• Exact location of the tumour

• Extent of spread

• Lymph node involvement

Overall stage of disease

Following HPV-positive confirmation, treatment is planned based on tumour size, stage, and patient health. This ensures a comprehensive and individualised approach to patient care.

Common treatment options include:

• Surgery 

  Minimally invasive techniques are available for tumour removal in appropriate cases. Surgery may also involve the excision of involved cervical lymph nodes.

• Radiation Therapy 

  Radiotherapy is utilised as a standalone or combined treatment. HPV-positive malignancies are typically more sensitive to radiation therapies.

• Chemotherapy

  Chemotherapy is recommended for advanced disease or as a sensitiser alongside radiation to enhance treatment results.

Multidisciplinary Care Management is coordinated by a specialist group, including:

• Head and neck surgeon

• Radiation oncologist

• Medical oncologist

• Speech and swallowing therapist

• Nutrition specialist

Post-intervention, patients are evaluated for adverse reactions and recovery milestones. Nutritional intake and swallowing mechanics are monitored throughout this period.

Common temporary effects include:

• Sore throat

• Difficulty swallowing

• Fatigue

• Dry mouth

Strict adherence to follow-up schedules is necessary to monitor recovery and facilitate the early detection of any secondary tumour growth.

Risks are associated with the disease and the treatment's toxicities. Management protocols are designed to identify and mitigate these factors throughout the patient journey.

Possible issues include:

• Difficulty swallowing

• Speech changes

• Dry mouth due to radiation therapy

• Dental problems

• Neck stiffness

Emotional and psychological stress

Cancers associated with HPV often have a more positive outlook than tobacco-related cancers, especially when diagnosed at an early point.

Early diagnosis may help to:

• Improve survival rates

• Reduce the need for aggressive treatment

• Preserve speech and swallowing function

• Minimise long-term complications

• Improve overall quality of life

HPV-related head and neck cancers demand precise diagnostic evaluation and coordinated treatment. Gleneagles Hospitals employs a multidisciplinary team with extensive experience in treating these complex malignancies.

Hospital facilities include:

• ENT and head & neck specialists

• Diagnostic CT, MRI, and PET-CT

• On-site pathology and HPV testing

• Minimally invasive surgical techniques

• Radiation and medical oncology

• Speech, swallowing, and nutritional support

• Structured follow-up protocols

Patients are supported throughout the clinical process, from evaluation to recovery. The management goal focuses on cancer control while preserving vital functions such as speech, swallowing, and overall quality of life.

Growing rates of HPV-related head and neck cancers necessitate a proactive medical approach. Although these malignancies often affect younger, healthy individuals, they respond exceptionally well to modern treatments. By combining advanced diagnostic imaging with a multidisciplinary planning process, patients can achieve excellent survival rates and preserve their quality of life. 

Widespread HPV vaccination, increased awareness of symptoms, and early medical consultations remain the most effective ways to reduce the disease's long-term impact and ensure a successful recovery for patients.